Your browser doesn't support javascript.
loading
Clinical Characteristics of COVID-19 from the Otorhinolaryngologist's Perspective: First Report from Oman, Middle East.
Kolethekkat, Arif Ali; Al Abri, Rashid; Al Washahi, Mohammed; Al Badaai, Yahya; Balkhair, Abdullah A.
Afiliação
  • Kolethekkat AA; ENT Division, Department of Surgery, College of Medicine and Health Sciences, Sultan Qaboos University Hospital, Al Khoud, P. O. Box 35, 123 Seeb, Oman.
  • Al Abri R; ENT Division, Department of Surgery, College of Medicine and Health Sciences, Sultan Qaboos University Hospital, Al Khoud, P. O. Box 35, 123 Seeb, Oman.
  • Al Washahi M; ENT Division, Department of Surgery, College of Medicine and Health Sciences, Sultan Qaboos University Hospital, Al Khoud, P. O. Box 35, 123 Seeb, Oman.
  • Al Badaai Y; ENT Division, Department of Surgery, College of Medicine and Health Sciences, Sultan Qaboos University Hospital, Al Khoud, P. O. Box 35, 123 Seeb, Oman.
  • Balkhair AA; Infectious Disease Unit, Department of Medicine, Sultan Qaboos University Hospital, Seeb, Oman.
Indian J Otolaryngol Head Neck Surg ; 74(Suppl 2): 3104-3110, 2022 Oct.
Article em En | MEDLINE | ID: mdl-34458130
To study the otorhinolaryngological clinical characteristics of COVID-19 positive patients. A prospective cross sectional study on sixty five patients who were SARS-CoV-2 PCR positive, and completed 14 days of isolation period were surveyed with a questionnaire. The responses were evaluated and assessed. Sixty five SARS-Cov-2 PCR positive cases were included in the study. There were 57 (87.6%) males and 8 (12.3%) females. Thirty five (53.8%) were in home isolation, whereas, 30 (46.2%) were under institutional care. Forty five patients (72.6%) presented with mild symptoms, and 4 (6.4%) developed moderate symptoms. Thirteen (21%) were asymptomatic. Overall, 46 patients (70.7%) presented with upper airway symptoms with or without general symptoms. More than half of the patients experienced pharyngodynia or sorethroat, smell and taste dysfunction as common symptoms (66.7%, 61.4% and 50.7% respectively). Severe headache was noticed by eighteen (27.7%) patients. Other respiratory symptoms such as nasal congestion, rhinorrhoea, sneezing, facial pain, etc. were present with less frequency. In more than half of the patients (61.5%), all the symptoms recovered within 5 days, in 12 (18.5%) between 5 and 8 days, and in 9 (13.8%), between 9 and14 days. However, in four patients, symptoms lasted for 28-30 days. In seven patients (10.7%), symptoms recurred after the period of isolation, however, the retest was negative. Fever, cough and or shortness of breath are the commonly reported prominent symptoms of COVID-19, however, there is a changing trend of clinical presentation towards variable otorhinolaryngologic manifestations. Pharyngodynia, taste and smell dysfunctions are common in patients with COVID-19, and could represent potential characters.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article